HSF1 is involved in immunotherapeutic response through regulating APOJ/STAT3-mediated PD-L1 expression in hepatocellular carcinoma

Hepatocellular cancer (HCC) is a serious illness with high prevalence and mortality throughout the whole world. For advanced HCC, immunotherapy is somewhat impactful and encouraging. Nevertheless, a substantial proportion of patients with advanced HCC are still unable to achieve a durable response,...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Hongxia, Wang, Sikai, Huang, Aidan, Ma, Jing, Gao, Dongmei, Li, Miaomiao, Chen, Huaping, Guo, Kun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746510/
https://www.ncbi.nlm.nih.gov/pubmed/36482717
http://dx.doi.org/10.1080/15384047.2022.2156242

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746510/
https://www.ncbi.nlm.nih.gov/pubmed/36482717
http://dx.doi.org/10.1080/15384047.2022.2156242

Ejemplares similares